ZQBLCZIBJYDTKD-UHFFFAOYSA-N 1-(3-fluorophenyl)-3-[3-(3-morpholin-4-ylquinoxalin-6-
yl) oxyphenyl] urea Chemical compound FC1= CC= CC (NC (= O) NC= 2C= C (OC= 3C …

US9688635B2 - Certain chemical entities, compositions, and methods - Google Patents
US9688635B2 - Certain chemical entities, compositions, and methods - Google Patents Certain …

US9572808B2 - Benzenesulfonamide derivatives of quinoxaline, pharmaceutical
compositions thereof, and their use in methods for treating cancer - Google Patents …

0 [1*] C1= C ([2*]) N= C2C (= N1) C ([5*])= C (C (= O) C1= C ([10*]) C (N ([9*])[11*])= C ([8*])
C ([7*])= C1 [6*]) C ([4*])= C2 [3*] Chemical compound [1*] C1= C ([2*]) N= C2C (= N1) C …

2010-09-13 Assigned to BOEHRINGER INGELHEIM INTERNATIONAL GMBH reassignment
BOEHRINGER INGELHEIM INTERNATIONAL GMBH ASSIGNMENT OF ASSIGNORS …

Chemical entities based on quinoxaline that are kinase inhibitors are described. Specifically
quinoxaline derivatives of Formula I, containing a diarylamide or diarylurea sub structure …

5,033,252 A 7, 1991 Carter 5,052,558 A 10, 1991 Carter 5,323,907 A 6/1994 Kalvelage
5,846,514 A 12/1998 Foster et al. 6,334,997 B1 1/2002 Foster et al. 6,348.461 Bl 2/2002 …

US9908866B2 - Certain chemical entities, compositions, and methods - Google Patents
US9908866B2 - Certain chemical entities, compositions, and methods - Google Patents Certain …

4, 464, 533 A 8/1984 Krass et al. 4, 761, 172 A 8/1988 Jahn et al. 5, 033, 252 A 7/1991
Carter 5, 052, 558 A 10/1991 Carter 5, 323, 907 A 6/1994 Kalvelage 5, 846, 514 A 12/1998 …

US10590106B2 - Certain chemical entities, compositions, and methods - Google Patents
US10590106B2 - Certain chemical entities, compositions, and methods - Google Patents …